Multisite thrombus imaging and fibrin content estimation with a single whole-body PET scan in rats

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 10, 2015, Pages 2114-2121

  Blasi, Francesco ^a   Oliveira, Bruno L ^a   Rietz, Tyson A ^a   Rotile, Nicholas J ^a   Naha, Pratap C ^b   Cormode, David P ^b   Izquierdo Garcia, David ^a   Catana, Ciprian ^a   Caravan, Peter ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

diagnostic techniques, cardiovascular; Fibrin; Magnetic resonance imaging; Molecular imaging; Positron emission tomography; Thrombosis; Whole body imaging

Indexed keywords

FERRIC CHLORIDE; FIBRIN BINDING PROBE CU 64; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; COPPER; FIBRIN;

ANIMAL EXPERIMENT; ARTERY THROMBOSIS; ARTICLE; AUTORADIOGRAPHY; CAROTID ARTERY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DRUG DISTRIBUTION; DRUG UPTAKE; EX VIVO STUDY; FEMORAL VEIN; HISTOPATHOLOGY; NON INVASIVE PROCEDURE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SPRAGUE DAWLEY RAT; THROMBUS; VEIN THROMBOSIS; WHOLE BODY IMAGING; ANIMAL; DISEASE MODEL; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; NEEDLE BIOPSY; PATHOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RANDOMIZATION; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; BIOPSY, NEEDLE; COPPER RADIOISOTOPES; DISEASE MODELS, ANIMAL; FIBRIN; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; POSITRON-EMISSION TOMOGRAPHY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY; VENOUS THROMBOSIS; WHOLE BODY IMAGING;

EID: 84942247236     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.306055     Document Type: Article

References (37)

1. Go AS, Mozaffarian D, Roger VL, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2014 update: A report from the American Heart Association. Circulation. 2014;129:e28-e292. doi: 10. 1161/01. cir. 0000441139. 02102. 80.
2. Srichai MB, Junor C, Rodriguez LL, Stillman AE, Grimm RA, Lieber ML, Weaver JA, Smedira NG, White RD. Clinical, imaging, and pathological characteristics of left ventricular thrombus: A comparison of contrastenhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J. 2006;152:75-84. doi: 10. 1016/j. Ahj. 2005. 08. 021.
3. Pomero F, Dentali F, Borretta V, Bonzini M, Melchio R, Douketis JD, Fenoglio LM. Accuracy of emergency physician-performed ultrasonography in the diagnosis of deep-vein thrombosis: A systematic review and meta-analysis. Thromb Haemost. 2013;109:137-145. doi: 10. 1160/ TH12-07-0473.
4. Fedullo PF, Tapson VF. Clinical practice. The evaluation of suspected pulmonary embolism. N Engl J Med. 2003;349:1247-1256. doi: 10. 1056/ NEJMcp035442.
5. Moulin T, Cattin F, Crépin-Leblond T, Tatu L, Chavot D, Piotin M, Viel JF, Rumbach L, Bonneville JF. Early CT signs in acute middle cerebral artery infarction: predictive value for subsequent infarct locations and outcome. Neurology. 1996;47:366-375.
6. Silvain J, Collet JP, Nagaswami C, Beygui F, Edmondson KE, Bellemain-Appaix A, Cayla G, Pena A, Brugier D, Barthelemy O, Montalescot G, Weisel JW. Composition of coronary thrombus in acute myocardial infarction. J Am Coll Cardiol. 2011;57:1359-1367. doi: 10. 1016/j. jacc. 2010. 09. 077.
7. Mehta BP, Nogueira RG. Should clot composition affect choice of endovascular therapy? Neurology. 2012;79(13 Suppl 1):S63-S67. doi: 10. 1212/WNL. 0b013e3182695859.
8. Buxton DB, Antman M, Danthi N, Dilsizian V, Fayad ZA, Garcia MJ, Jaff MR, Klimas M, Libby P, Nahrendorf M, Sinusas AJ, Wickline SA, Wu JC, Bonow RO, Weissleder R. Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging. Circulation. 2011;123:2157-2163. doi: 10. 1161/CIRCULATIONAHA. 110. 000943.
9. Lindner JR. Molecular imaging of thrombus: technology in evolution. Circulation. 2012;125:3057-3059. doi: 10. 1161/CIRCULATIONAHA. 112. 112672.
10. Mitchel J, Waters D, Lai T, White M, Alberghini T, Salloum A, Knibbs D, Li D, Heller GV. Identification of coronary thrombus with a IIb/IIIa platelet inhibitor radiopharmaceutical, technetium-99m DMP-444: A canine model. Circulation. 2000;101:1643-1646.
11. Wang X, Hagemeyer CE, Hohmann JD, Leitner E, Armstrong PC, Jia F, Olschewski M, Needles A, Peter K, Ahrens I. Novel single-chain antibodytargeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice. Circulation. 2012;125:3117-3126. doi: 10. 1161/CIRCULATIONAHA. 111. 030312.
12. Wiethoff AJ, Laredo J, Hamilton J, Quist W, Parsons EC Jr, Vaidya A, Kolodziej A, Barrett JA, Graham PB, Weisskoff RM, Manning WJ, Johnstone MT. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation. 2004;109:2023-2029. doi: 10. 1161/01. CIR. 0000127034. 50006. C0.
13. Morris TA, Gerometta M, Yusen RD, White RH, Douketis JD, Kaatz S, Smart RC, Macfarlane D, Ginsberg JS. Detection of pulmonary emboli with 99mTc-labeled anti-D-dimer (DI-80B3)Fab' fragments (ThromboView). Am J Respir Crit Care Med. 2011;184:708-714. doi: 10. 1164/rccm. 201104-0624OC.
14. Ciesienski KL, Caravan P. Molecular MRI of Thrombosis. Curr Cardiovasc Imaging Rep. 2010;4:77-84. doi: 10. 1007/s12410-010-9061-5.
15. Uppal R, Catana C, Ay I, Benner T, Sorensen AG, Caravan P. Bimodal thrombus imaging: simultaneous PET/MR imaging with a fibrin-targeted dual PET/MR probe-feasibility study in rat model. Radiology. 2011;258:812-820. doi: 10. 1148/radiol. 10100881.
16. Ciesienski KL, Yang Y, Ay I, Chonde DB, Loving GS, Rietz TA, Catana C, Caravan P. Fibrin-targeted PET probes for the detection of thrombi. Mol Pharm. 2013;10:1100-1110. doi: 10. 1021/mp300610s.
17. Ay I, Blasi F, Rietz TA, Rotile NJ, Kura S, Brownell AL, Day H, Oliveira BL, Looby RJ, Caravan P. In vivo molecular imaging of thrombosis and thrombolysis using a fibrin-binding positron emission tomographic probe. Circ Cardiovasc Imaging. 2014;7:697-705. doi: 10. 1161/ CIRCIMAGING. 113. 001806.
18. Blasi F, Oliveira BL, Rietz TA, Rotile NJ, Day H, Looby RJ, Ay I, Caravan P. Effect of chelate type and radioisotope on the imaging efficacy of 4 fibrin-specific PET probes. J Nucl Med. 2014;55:1157-1163. doi: 10. 2967/jnumed. 113. 136275.
19. Boros E, Rybak-Akimova E, Holland JP, Rietz T, Rotile N, Blasi F, Day H, Latifi R, Caravan P. Pycup-a bifunctional, cage-like ligand for (64)Cu radiolabeling. Mol Pharm. 2014;11:617-629. doi: 10. 1021/ mp400686z.
20. Kolodziej AF, Nair SA, Graham P, McMurry TJ, Ladner RC, Wescott C, Sexton DJ, Caravan P. Fibrin specific peptides derived by phage display: characterization of peptides and conjugates for imaging. Bioconjug Chem. 2012;23:548-556. doi: 10. 1021/bc200613e.
21. Overoye-Chan K, Koerner S, Looby RJ, Kolodziej AF, Zech SG, Deng Q, Chasse JM, McMurry TJ, Caravan P. EP-2104R: A fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus. J Am Chem Soc. 2008;130:6025-6039. doi: 10. 1021/ja800834y.
22. Kurz KD, Main BW, Sandusky GE. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res. 1990;60:269-280.
23. Lendrum AC, Fraser DS, Slidders W, Henderson R. Studies on the character and staining of fibrin. J Clin Pathol. 1962;15:401-413.
24. Saha P, Andia ME, Modarai B, et al. Magnetic resonance T1 relaxation time of venous thrombus is determined by iron processing and predicts susceptibility to lysis. Circulation. 2013;128:729-736. doi: 10. 1161/ CIRCULATIONAHA. 113. 001371.
25. Phinikaridou A, Andia ME, Saha P, Modarai B, Smith A, Botnar RM. In vivo magnetization transfer and diffusion-weighted magnetic resonance imaging detects thrombus composition in a mouse model of deep vein thrombosis. Circ Cardiovasc Imaging. 2013;6:433-440. doi: 10. 1161/ CIRCIMAGING. 112. 000077.
26. Andia ME, Saha P, Jenkins J, Modarai B, Wiethoff AJ, Phinikaridou A, Grover SP, Patel AS, Schaeffter T, Smith A, Botnar RM. Fibrintargeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis. Arterioscler Thromb Vasc Biol. 2014;34:1193-1198. doi: 10. 1161/ ATVBAHA. 113. 302931.
27. Purroy F, Montaner J, Molina CA, Delgado P, Ribo M, Alvarez-Sabín J. Patterns and predictors of early risk of recurrence after transient ischemic attack with respect to etiologic subtypes. Stroke. 2007;38:3225-3229. doi: 10. 1161/STROKEAHA. 107. 488833.
28. Schaer B, Sticherling C, Lyrer P, Osswald S. Cardiological diagnostic work-up in stroke patients-a comprehensive study of test results and therapeutic implications. Eur J Neurol. 2009;16:268-273. doi: 10. 1111/j. 1468-1331. 2008. 02413. x.
29. Guercini F, Acciarresi M, Agnelli G, Paciaroni M. Cryptogenic stroke: time to determine aetiology. J Thromb Haemost. 2008;6:549-554. doi: 10. 1111/j. 1538-7836. 2008. 02903. x.
30. Fuster V, Fayad ZA, Moreno PR, Poon M, Corti R, Badimon JJ. Atherothrombosis and high-risk plaque: Part II: Approaches by noninvasive computed tomographic/magnetic resonance imaging. J Am Coll Cardiol. 2005;46:1209-1218. doi: 10. 1016/j. jacc. 2005. 03. 075.
31. Kramer MC, Rittersma SZ, de Winter RJ, Ladich ER, Fowler DR, Liang YH, Kutys R, Carter-Monroe N, Kolodgie FD, van der Wal AC, Virmani R. Relationship of thrombus healing to underlying plaque morphology in sudden coronary death. J Am Coll Cardiol. 2010;55:122-132. doi: 10. 1016/j. jacc. 2009. 09. 007.
32. Brommer EJ, Potter van Loon BJ, Rijken DC, van Bockel JH. Composition and susceptibility to thrombolysis of pathological human arterial thrombi. Ann N Y Acad Sci. 1992;667:283-285.
33. Geier B, Barbera L, Muth-Werthmann D, Siebers S, Ermert H, Philippou S, Mumme A. Ultrasound elastography for the age determination of venous thrombi. Evaluation in an animal model of venous thrombosis. Thromb Haemost. 2005;93:368-374. doi: 10. 1267/ THRO05020368.
34. Vymazal J, Spuentrup E, Cardenas-Molina G, Wiethoff AJ, Hartmann MG, Caravan P, Parsons EC, Jr. Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility. Invest Radiol. 2009;44:697-704. doi: 10. 1097/ RLI. 0b013e3181b092a7.
35. Brighton T, Janssen J, Butler SP. Aging of acute deep vein thrombosis measured by radiolabeled 99mTc-rt-PA. J Nucl Med. 2007;48:873-878. doi: 10. 2967/jnumed. 106. 039396.
36. Hara T, Truelove J, Tawakol A, Wojtkiewicz GR, Hucker WJ, MacNabb MH, Brownell AL, Jokivarsi K, Kessinger CW, Jaff MR, Henke PK, Weissleder R, Jaffer FA. 18F-fluorodeoxyglucose positron emission tomography/computed tomography enables the detection of recurrent same-site deep vein thrombosis by illuminating recently formed, neutrophil-rich thrombus. Circulation. 2014;130:1044-1052. doi: 10. 1161/CIRCULATIONAHA. 114. 008902.
37. Blasi F, Oliveira BL, Rietz TA, Rotile NJ, Day H, Naha PC, Cormode DP, Izquierdo-Garcia D, Catana C, Caravan P. Radiation dosimetry of the fibrin-binding probe 64Cu-FBP8 and its feasibility for PET imaging of deep vein thrombosis and pulmonary embolism in rats. J Nucl Med. 2015;56:1088-1093. doi: 10. 2967/jnumed. 115. 157982.